June 2021
Volume 62, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2021
Evaluation of an Artificial Intelligence System (i-ROP DL) for Retinopathy of Prematurity Screening in Nepal using the Forus 3nethra neo and in Mongolia using the Retcam Portable®
Author Affiliations & Notes
  • Tala Al-Khaled
    Illinois Eye and Ear Infirmary, Department of Ophthalmology and Visual Sciences, University of Illinois at Chicago, Chicago, Illinois, United States
  • Nita Valikodath
    Illinois Eye and Ear Infirmary, Department of Ophthalmology and Visual Sciences, University of Illinois at Chicago, Chicago, Illinois, United States
  • Emily Cole
    Illinois Eye and Ear Infirmary, Department of Ophthalmology and Visual Sciences, University of Illinois at Chicago, Chicago, Illinois, United States
  • Sanyam Bajimaya
    Tilganga Institute of Ophthalmology, Kathmandu, Nepal
  • Sagun KC
    Helen Keller International, Kathmandu, Nepal
  • Tsengelmaa Chuluunbat
    National Center for Maternal and Child Health of Mongolia, Ulaanbaatar, Ulaanbaatar, Mongolia
  • Karyn Jonas
    Illinois Eye and Ear Infirmary, Department of Ophthalmology and Visual Sciences, University of Illinois at Chicago, Chicago, Illinois, United States
  • Chimgee Chuluunkhuu
    ORBIS International, New York, New York, United States
  • Leslie D. MacKeen
    The Hospital for Sick Children, Toronto, Ontario, Canada
  • Susan Ostmo
    Oregon Health & Science University Casey Eye Institute, Portland, Oregon, United States
  • Wei-Chi Wu
    Chang Gung Medical Foundation, Taoyuan, Taiwan
  • Praveer Singh
    Harvard Medical School, Boston, Massachusetts, United States
  • Jayashree Kalpathy-Cramer
    Harvard Medical School, Boston, Massachusetts, United States
  • Michael F Chiang
    National Eye Institute, Bethesda, Maryland, United States
  • J. Peter Campbell
    Oregon Health & Science University Casey Eye Institute, Portland, Oregon, United States
  • Robison Vernon Paul Chan
    Illinois Eye and Ear Infirmary, Department of Ophthalmology and Visual Sciences, University of Illinois at Chicago, Chicago, Illinois, United States
  • Footnotes
    Commercial Relationships   Tala Al-Khaled, None; Nita Valikodath, None; Emily Cole, None; Sanyam Bajimaya, None; Sagun KC, None; Tsengelmaa Chuluunbat, None; Karyn Jonas, None; Chimgee Chuluunkhuu, None; Leslie MacKeen, Phoenix Technology Group, LLC (Pleasanton, CA) (E); Susan Ostmo, None; Wei-Chi Wu, None; Praveer Singh, None; Jayashree Kalpathy-Cramer, Genentech (F); Michael Chiang, Genentech (F), InTeleretina LLC (I), National Institutes of Health (F), National Science Foundation (F), Novartis (C); J. Peter Campbell, Genentech (F), National Institutes of Health (F), Research to Prevent Blindness (F); Robison Chan, Consultant for Alcon (Fort Worth, Texas) (C), Genentech (F), National Institutes of Health (Bethesda, MD) (F), Novartis (South San Francisco, CA) (C), Regeneron (F), Research to Prevent Blindness (New York, NY) (F), Scientific Advisory Board for Phoenix Technology Group, LLC (Pleasanton, CA) (S)
  • Footnotes
    Support  Grants R01EY19474, K12EY027720, P30 EY001792 and P30EY10572 from the National Institutes of Health (Bethesda, MD); grants SCH-1622679, SCH-1622542, and SCH-1622536 from the National Science Foundation (Arlington, VA); VitreoRetinal Surgery Foundation; unrestricted departmental funding and a Career Development Award from Research to Prevent Blindness (New York, NY); Ulverscroft Foundation (UK); United States Agency for International Development Child Blindness Program (Washington, DC).
Investigative Ophthalmology & Visual Science June 2021, Vol.62, 3269. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Tala Al-Khaled, Nita Valikodath, Emily Cole, Sanyam Bajimaya, Sagun KC, Tsengelmaa Chuluunbat, Karyn Jonas, Chimgee Chuluunkhuu, Leslie D. MacKeen, Susan Ostmo, Wei-Chi Wu, Praveer Singh, Jayashree Kalpathy-Cramer, Michael F Chiang, J. Peter Campbell, Robison Vernon Paul Chan; Evaluation of an Artificial Intelligence System (i-ROP DL) for Retinopathy of Prematurity Screening in Nepal using the Forus 3nethra neo and in Mongolia using the Retcam Portable®. Invest. Ophthalmol. Vis. Sci. 2021;62(8):3269.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Our group has demonstrated the performance of the i-ROP Deep Learning (DL) system for retinopathy of prematurity (ROP) telemedicine screening programs in Nepal and Mongolia. The purpose of this study is to evaluate the performance of i-ROP DL in Nepal and Mongolia when increasing the number of infants included and conducting further analysis by country and fundus camera.

Methods : This retrospective study evaluated prospectively collected data from ROP screening programs in Nepal and Mongolia. Birth weight, gestational age, and ROP severity based on the International Classification of ROP (ICROP) guidelines were recorded. Fundus images were obtained with the Forus 3nethra neo in Nepal and the RetCam® Portable in Mongolia. The i-ROP DL system, previously trained on RetCam® images, was used to identify posterior pole images in the dataset and subsequently generated a mean vascular severity score (1-9). Analysis of variance was used to compare vascular severity scores to ROP categories by country. A p value ≤ 0.05 was considered statistically significant. Stata MP 13, SAS, and R statistical software programs were used.

Results : There were a total of 377 patients and 860 exams in Nepal and 321 patients and 917 exams in Mongolia. Average birth weight and gestational age were lower in Mongolia compared to Nepal (both p < 0.001). Overall disease prevalence of treatment-requiring ROP was 14% in Mongolia vs 2% in Nepal (p < 0.001). See Table 1. The ROP vascular severity score was higher in Mongolia compared to Nepal at the population level (3.5 vs. 2.5, p < 0.002). Figure 1 displays the vascular severity scores overall and by category for Nepal and Mongolia.

Conclusions : In Mongolia and Nepal, the AI-generated vascular severity scores correspond to ICROP disease severity using two different camera systems, despite the i-ROP DL system not being previously trained on Forus 3nethra neo images. Vascular severity at the population level may be a useful tool for epidemiologic assessment of geographic and temporal variations in ROP severity.

This is a 2021 ARVO Annual Meeting abstract.

 

Demographic data and rates of ROP severity by category in Nepal and Mongolia.

Demographic data and rates of ROP severity by category in Nepal and Mongolia.

 

Retinopathy of prematurity (ROP) vascular severity scores in Nepal and Mongolia. The scores are presented for overall ROP severity and by category. Asterisks denote higher vascular severity scores.

Retinopathy of prematurity (ROP) vascular severity scores in Nepal and Mongolia. The scores are presented for overall ROP severity and by category. Asterisks denote higher vascular severity scores.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×